New type of recovery in HeLa cells exposed to bleomycin

A phase II study of pembrolizumab plus chemotherapy with short-course radiotherapy as induction treatment for unresectable locally advanced esophageal squamous cell carcinoma: PALADIN trial.

ESMO gastrointestinal oncology·2026

Effect of prior anti-EGFR therapy and baseline ctDNA profiling on the efficacy of pertuzumab plus trastuzumab in HER2-amplified metastatic colorectal cancer: an integrated analysis of TRIUMPH/MyPathway.

ESMO open·2026

Short- and mid-term outcomes of transanal/transperineal minimally invasive surgery for locally recurrent rectal cancer.

Techniques in coloproctology·2026

An open-label phase Ib/II study of trastuzumab deruxtecan combined with nivolumab and CAPOX for HER2-low gastroesophageal adenocarcinoma.

ESMO gastrointestinal oncology·2026

VOLTAGE-2: multicenter phase II study of nivolumab monotherapy in patients with mismatch repair-deficient resectable locally advanced rectal cancer.

ESMO gastrointestinal oncology·2026

ARCAD-Asia initiative: leveraging yesterday's data for tomorrow.

ESMO gastrointestinal oncology·2026

Preferences for the use of Artificial Intelligence (AI) technologies to help detect skin cancer in primary care settings: a UK-wide discrete choice experiment (DCE).

British journal of cancer·2026

Programmed death ligand 1 (PD-L1) PET/CT imaging to evaluate tumour saturation during atezolizumab treatment.

British journal of cancer·2026

Neoadjuvant triplet chemotherapy enables radiotherapy avoidance in human papillomavirus-associated oropharyngeal cancer: a multicentre Phase II trial.

British journal of cancer·2026

Translational modelling challenges receptor‑occupancy‑based dosing of PD‑1 inhibitors like pembrolizumab.

British journal of cancer·2026

PD-L1 expression and survival in unresectable/recurrent gastric cancer treated by 1st-line treatment without immune checkpoint inhibitors: JCOG1013A1.

British journal of cancer·2026

Radiomics as a spatial context for treatment decision-making in head and neck cancer.

British journal of cancer·2026

HydroMark Clip-Guided Cryoablation of a <3-mm Breast Cancer at the Lower Limit of Sonographic Conspicuity in a High-Risk Surgical Patient.

Cureus·2026

ID3-directed sonogenetics to enhance osteogenesis and bone defect healing.

International journal of oral science·2026

TNFAIP3 Modulates Macrophage Polarization Post-Myocardial Infarction through Its Restraint on the JAK2-STAT1 Signaling Axis.

International heart journal·2026

Targeting the NEAT1/miR-23b-3p/Glutaminase Axis.

International heart journal·2026

Bombyx mori silk fibroin alleviates alcohol-induced liver injury via modulation of the gut-liver axis.

International journal of biological macromolecules·2026

FABP3 regulates vascular remodeling and endothelial-mesenchymal transition through NF-κB activation in aged mice fed a high-fat diet.

International immunopharmacology·2026

Related Experiment Videos

New type of recovery in HeLa cells exposed to bleomycin

Related Concept Videos

A phase II study of pembrolizumab plus chemotherapy with short-course radiotherapy as induction treatment for unresectable locally advanced esophageal squamous cell carcinoma: PALADIN trial.

Effect of prior anti-EGFR therapy and baseline ctDNA profiling on the efficacy of pertuzumab plus trastuzumab in HER2-amplified metastatic colorectal cancer: an integrated analysis of TRIUMPH/MyPathway.

Short- and mid-term outcomes of transanal/transperineal minimally invasive surgery for locally recurrent rectal cancer.

An open-label phase Ib/II study of trastuzumab deruxtecan combined with nivolumab and CAPOX for HER2-low gastroesophageal adenocarcinoma.

VOLTAGE-2: multicenter phase II study of nivolumab monotherapy in patients with mismatch repair-deficient resectable locally advanced rectal cancer.

ARCAD-Asia initiative: leveraging yesterday's data for tomorrow.

Preferences for the use of Artificial Intelligence (AI) technologies to help detect skin cancer in primary care settings: a UK-wide discrete choice experiment (DCE).

Programmed death ligand 1 (PD-L1) PET/CT imaging to evaluate tumour saturation during atezolizumab treatment.

Neoadjuvant triplet chemotherapy enables radiotherapy avoidance in human papillomavirus-associated oropharyngeal cancer: a multicentre Phase II trial.

Translational modelling challenges receptor‑occupancy‑based dosing of PD‑1 inhibitors like pembrolizumab.

PD-L1 expression and survival in unresectable/recurrent gastric cancer treated by 1st-line treatment without immune checkpoint inhibitors: JCOG1013A1.

Radiomics as a spatial context for treatment decision-making in head and neck cancer.

HydroMark Clip-Guided Cryoablation of a <3-mm Breast Cancer at the Lower Limit of Sonographic Conspicuity in a High-Risk Surgical Patient.

ID3-directed sonogenetics to enhance osteogenesis and bone defect healing.

TNFAIP3 Modulates Macrophage Polarization Post-Myocardial Infarction through Its Restraint on the JAK2-STAT1 Signaling Axis.

Targeting the NEAT1/miR-23b-3p/Glutaminase Axis.

Bombyx mori silk fibroin alleviates alcohol-induced liver injury via modulation of the gut-liver axis.

FABP3 regulates vascular remodeling and endothelial-mesenchymal transition through NF-κB activation in aged mice fed a high-fat diet.

Related Experiment Videos

New type of recovery in HeLa cells exposed to bleomycin

Related Concept Videos

Related Articles